Biostar Pharmaceuticals Executives

BSPMDelisted Stock  USD 0.01  0.00  0.00%   
Biostar Pharmaceuticals employs about 200 people. The company is managed by 5 executives with a total tenure of roughly 52 years, averaging almost 10.0 years of service per executive, having 40.0 employees per reported executive. Analysis of Biostar Pharmaceuticals' management performance can provide insight into the firm performance.
Ronghua Wang  Chairman
Chairman, CEO and President Chairman of Aoxing Pharmaceutical Inc, CEO of Aoxing Pharmaceutical Inc and President of Aoxing Pharmaceutical Inc
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

Biostar Pharmaceuticals Management Team Effectiveness

The company has return on total asset (ROA) of 0.0425 % which means that it generated a profit of $0.0425 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0266 %, meaning that it created $0.0266 on every $100 dollars invested by stockholders. Biostar Pharmaceuticals' management efficiency ratios could be used to measure how well Biostar Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.

Biostar Pharmaceuticals Workforce Comparison

Biostar Pharmaceuticals is number one stock in number of employees category among its peers. The total workforce of Pharmaceuticals, Biotechnology & Life Sciences industry is currently estimated at about 4,599. Biostar Pharmaceuticals holds roughly 200 in number of employees claiming about 4% of equities listed under Pharmaceuticals, Biotechnology & Life Sciences industry.
The company has Profit Margin (PM) of 2.94 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is normal as compared to the sector avarege. Similarly, it shows Operating Margin (OM) of 8.76 %, which suggests for every 100 dollars of sales, it generated a net operating income of $8.76.

Biostar Pharmaceuticals Notable Stakeholders

A Biostar Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Biostar Pharmaceuticals often face trade-offs trying to please all of them. Biostar Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Biostar Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Ronghua WangChairman, CEO and President Chairman of Aoxing Pharmaceutical Inc, CEO of Aoxing Pharmaceutical Inc and President of Aoxing Pharmaceutical IncProfile
Zhenghong WangChief OfficerProfile
Pr ZhengChief ScientistProfile
Xiaojuan ZhaiChief OfficerProfile
Shuang GongSecretary of BoardProfile

About Biostar Pharmaceuticals Management Performance

The success or failure of an entity such as Biostar Pharmaceuticals often depends on how effective the management is. Biostar Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Biostar management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Biostar management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter and prescription pharmaceutical products for various diseases and conditions in the Peoples Republic of China. The company was incorporated in 2007 and is headquartered in Xianyang, the Peoples Republic of China. Biostar Pharmaceuticals operates under Pharmaceuticals And Biosciences classification in the United States and is traded on OTC Exchange. It employs 200 people.

Biostar Pharmaceuticals Workforce Analysis

Traditionally, organizations such as Biostar Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Biostar Pharmaceuticals within its industry.

Biostar Pharmaceuticals Manpower Efficiency

Return on Biostar Pharmaceuticals Manpower

Revenue Per Employee1.6K
Revenue Per Executive63.6K
Net Loss Per Employee28.5K
Net Loss Per Executive1.1M
Working Capital Per Employee45.3K
Working Capital Per Executive1.8M
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Consideration for investing in Biostar Pink Sheet

If you are still planning to invest in Biostar Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biostar Pharmaceuticals' history and understand the potential risks before investing.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
CEOs Directory
Screen CEOs from public companies around the world